Hua Medicine

Hua is a drug development company that focuses on novel therapies for the treatment of Type 2 diabetes and dyskinesia diseases.

Business Model:

Revenue: $4.2M

Employees: 51-200

Detailed Hua Medicine Information

Geographic Data

Hua Medicine headquarters map

Address: Xuelin Road

City: Pudong

State: shanghai municipality

Zip: 201203

Country: CN

Financial Info

Stage:

series e

Raised Last:

$0

Raised Total:

$242M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Hua is a drug development company that focuses on novel therapies for the treatment of Type 2 diabetes and dyskinesia diseases.

Contact Phone:

Contact Email:

Hua Medicine went public on 9/13/2018 on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

IPO Date:
9/13/2018

IPO Valuation:
$1B

Ticker Symbol:
2552

IPO Price:
$1.0550257066952082/share

Amount Raised:
$110M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2018 IPO $400M
1/2015 Series B $0 SAIL Capital Partners LLC
WuXi Healthcare Ventures
Venrock
TF Capital
Frontline BioVentures
Fidelity
ARCH Venture Partners
Ally Bridge Group
SAIL Capital Partners LLC
WuXi Healthcare Ventures
Venrock
TF Capital
Frontline BioVentures
Fidelity
ARCH Venture Partners
Ally Bridge Group
8/2010 Venture Round 1 - Eight Roads Ventures
Eight Roads Ventures
9/2011 Series A 6 $50M WuXi Healthcare Ventures
Venrock
Sino-Alliance International Ltd
F-Prime Capital
Eight Roads Ventures
ARCH Venture Partners
3/2018 Series D $0 ARCH Venture Partners
GIC
K11 Investment
6 Dimensions Capital
Eight Roads Ventures
Venrock
Mirae Asset Global Investments
Ally Bridge Group
Harvest Capital
Blue Pool Capital
F-Prime Capital
Ping An Ventures
WuXi AppTec
ARCH Venture Partners
GIC
K11 Investment
6 Dimensions Capital
Eight Roads Ventures
Venrock
Mirae Asset Global Investments
Ally Bridge Group
Harvest Capital
Blue Pool Capital
F-Prime Capital
Ping An Ventures
WuXi AppTec
3/2018 Series E -
4/2016 Series C $0 Harvest Global Investments
SAIL Capital Partners LLC
WuXi Healthcare Ventures
Venrock
TF Capital
Frontline BioVentures
F-Prime Capital
Eight Roads Ventures
ARCH Venture Partners
Ally Bridge Group
Harvest Global Investments
SAIL Capital Partners LLC
WuXi Healthcare Ventures
Venrock
TF Capital
Frontline BioVentures
F-Prime Capital
Eight Roads Ventures
ARCH Venture Partners
Ally Bridge Group
3/2018 Series D 13 $117.4M Blue Pool Capital Limited
GIC Private Limited
6 Dimensions Capital
Ping An Ventures
Mirae Asset Financial Group
ARCH Venture Partners
GIC
K11 Investment
6 Dimensions Capital
Eight Roads Ventures
Venrock
Mirae Asset Global Investments
Ally Bridge Group
Harvest Capital
Blue Pool Capital
4/2016 Series C 10 $50M Harvest Investments
Frontline BioVentures
ARCH Venture Partners
Venrock
Fidelity
WuXi Ventures
Harvest Global Investments
1/2015 Series B 8 $25M Frontline BioVentures
ARCH Venture Partners
Venrock
WuXi Venture Fund
3/2018 Series E -
8/2010 Venture Round 1 -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research